Teladoc Health, Inc. (NYSE:TDOC - Get Free Report)'s stock price fell 5% on Wednesday . The company traded as low as $12.27 and last traded at $12.39. 4,408,114 shares changed hands during trading, a decline of 22% from the average session volume of 5,644,407 shares. The stock had previously closed at $13.04.
Analysts Set New Price Targets
A number of research firms have recently weighed in on TDOC. Deutsche Bank Aktiengesellschaft increased their price objective on Teladoc Health from $10.00 to $12.00 and gave the company a "hold" rating in a research note on Friday, November 1st. Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Piper Sandler reaffirmed an "overweight" rating and issued a $13.00 price target (up previously from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. Barclays raised their price target on Teladoc Health from $10.00 to $12.00 and gave the stock an "overweight" rating in a research note on Thursday, October 31st. Finally, Bank of America raised their price target on Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a research note on Wednesday, February 12th. Fourteen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Teladoc Health presently has an average rating of "Hold" and a consensus target price of $12.18.
Check Out Our Latest Report on TDOC
Teladoc Health Price Performance
The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a fifty day moving average price of $10.41 and a two-hundred day moving average price of $9.35. The stock has a market capitalization of $2.26 billion, a P/E ratio of -2.27 and a beta of 1.05.
Insider Activity
In other news, insider Carlos Nueno sold 2,389 shares of the firm's stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares in the company, valued at $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.95% of the company's stock.
Hedge Funds Weigh In On Teladoc Health
Several institutional investors and hedge funds have recently modified their holdings of TDOC. CWM LLC increased its holdings in Teladoc Health by 219.1% in the 3rd quarter. CWM LLC now owns 13,557 shares of the health services provider's stock worth $124,000 after buying an additional 9,309 shares in the last quarter. Creative Planning increased its holdings in Teladoc Health by 184.7% in the 3rd quarter. Creative Planning now owns 64,125 shares of the health services provider's stock worth $589,000 after buying an additional 41,602 shares in the last quarter. Blue Trust Inc. increased its holdings in Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider's stock worth $40,000 after buying an additional 1,854 shares in the last quarter. Signaturefd LLC increased its holdings in Teladoc Health by 162.7% in the 3rd quarter. Signaturefd LLC now owns 7,535 shares of the health services provider's stock worth $69,000 after buying an additional 4,667 shares in the last quarter. Finally, Private Advisor Group LLC increased its holdings in Teladoc Health by 26.9% in the 3rd quarter. Private Advisor Group LLC now owns 13,990 shares of the health services provider's stock worth $128,000 after buying an additional 2,962 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors.
About Teladoc Health
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
See Also
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
